USPTO serial 79340019
VIVOLTA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 7, 2023
- Examiner
- MALYSZEK, KIMBERLY RAY
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with VIVOLTA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
NL
Innovative Mechanical Engineering Technologies B.V.
NL
Other trademarks owned by Innovative Mechanical Engineering Technologies B.V.
Innovative Mechanical Engineering Technologies B.V.
NL
Other trademarks owned by Innovative Mechanical Engineering Technologies B.V.
Innovative Mechanical Engineering Technologies B.V.
NL
Other trademarks owned by Innovative Mechanical Engineering Technologies B.V.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mary Catherine Merz
Mary Catherine Merz Merz & Associates, P.C.408 Madison St., Suite AOak Park, IL 60302UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | sanitary preparations for medical use; pharmaceutical implants, namely, surgical implants comprised of living tissues; surgical implants for guided tissue regeneration comprised of living tissues; surgical implants grown from stem cells comprised of living tissues; biological implants comprised of live tissues and organs; biodegradable implants comprised of living tissues; surgical implants comprised of living tissues; implants for osteosynthesis comprised of living tissues; wound dressings; surgical and medical implants comprised of living cells; medicinal preparations for wound healing comprised of living cells | ACTIVE | — |
| 007 | Electrospinning machines for manufacturing fiber-based medical devices and pharmaceutical products in the nature of artificial tissue scaffolds and matrices, artificial scaffolds and matrices for local drug delivery, artificial scaffolds and matrices for targeted drug delivery, and artificial extracellular matrices; melt electrowriting machines for manufacturing fiber-based medical devices and pharmaceutical products in the nature of artificial tissue scaffolds and matrices, artificial scaffolds and matrices for local drug delivery, artificial scaffolds and matrices for targeted drug delivery, and artificial extracellular matrices; melt spinning machines for manufacturing fiber-based medical devices and pharmaceutical products in the nature of artificial tissue scaffolds and matrices, artificial scaffolds and matrices for local drug delivery, artificial scaffolds and matrices for targeted drug delivery, and artificial extracellular matrices; electrospraying machines for coating of medical devices and pharmaceutical products in the nature of artificial tissue scaffolds and matrices, artificial scaffolds and matrices for local drug delivery, artificial scaffolds and matrices for targeted drug delivery, and artificial extracellular matrices; 3D printing machines; structural parts of electrospinning machines, electrospraying machines, melt electrospinning machines, melt spinning machines and 3D printing machines | ACTIVE | — |
| 010 | Surgical devices and instruments; artificial limbs, eyes and teeth; orthopedic articles, namely, orthopedic supports and braces; suture materials; surgical implants in the nature of artificial organs; medical implants comprised of artificial materials; orthopedic implants comprised of artificial materials; surgical implants in the nature prosthesis ; dental implants; implanted prosthesis, namely, implanted ligaments comprised or artificial materials; implants for ligaments in the nature prosthesis comprised of artificial materials; implants for bone surgery in the nature of prosthesis comprised of artificial materials; implants for use in bone grafting in the nature prosthesis comprised of artificial materials; ocular and intra-ocular implants in the nature prosthesis comprised of artificial materials; intravascular implants in the nature prosthesis comprised of artificial materials; implants for use in tendons in the nature prosthesis comprised of artificial materials; implants for use in facial surgery in the nature prosthesis comprised of artificial materials; implants for use in cosmetic surgery and breast reconstruction in the nature prosthesis comprised of artificial materials; implants for use in soft tissue repair in the nature prosthesis comprised of artificial materials; implants for use in repair of women's reproductive organs in the nature prosthesis comprised of artificial materials; implants for use in wound healing in the nature prosthesis comprised of artificial materials; implants for use in vascular and cardiovascular surgery in the nature prosthesis comprised of artificial materials; implantable drug delivery ports and pumps; biomaterials for soft tissue repair in the nature implanted prosthesis comprised of artificial materials; surgical implants and mesh made of synthetic or artificial materials for use in soft tissue repair or the reconstruction of soft tissue deficiencies; surgical implants and mesh made of artificial materials, namely, of nanofiber-based or electrospun biomaterial for use in soft tissue repair or the reconstruction of soft tissue deficiencies; medical devices and apparatuses, namely, surgical implants or mesh made of artificial materials, namely, of artificial biomaterial for use in repair, reinforcement or buttressing of soft tissue and parts and fittings therefor; artificial biomaterials for augmentation of bone or soft tissue for medical purposes; implants comprised of artificial non-living materials; medical devices, namely, nanofiber-based implantable vascular and cardiovascular devices, nanofiber-based stents and nanofiber-covered stents; surgical mesh prosthesis of artificial materials for general surgery; nanofiber-based implants for tissue repair and repair of women's reproductive organs in the nature prosthesis comprised of artificial materials; nanofiber-based drug delivery ports and pumps; surgical meshes comprised of artificial materials for the repair, regeneration and reinforcement of soft tissues; biodegradable bone fixation implants and other similar implants for surgical and medical use comprised of artificial materials | ACTIVE | — |
| 042 | Scientific and technological services, namely, research, engineering and design in the field of electrospinning, electrospraying, melt electrospinning writing, melt spinning and 3D printing machines and techniques; creating, maintaining and updating computer software for electro spinning machines, melt electrospinning writing machines, melt spinning machines and 3D printing machines | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Vivolta B.V.
- Other trademarks owned by Innovative Mechanical Engineering Technologies B.V.
- Other trademarks owned by Innovative Mechanical Engineering Technologies B.V.
- Other trademarks owned by Innovative Mechanical Engineering Technologies B.V.
- Other trademarks in Class 005
- Other trademarks in Class 007
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named VIVOLTA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 2, 2026 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jul 26, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 12, 2023 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Jun 11, 2023 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Jun 7, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 7, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Mar 7, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 22, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 20, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 20, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 30, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 30, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 30, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 15, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 14, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 14, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 14, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 13, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 7, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 19, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 19, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 17, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 17, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 16, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 13, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| May 13, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 12, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |